American Healthcare REIT, Inc. launched a $1,750,000,000 ATM common stock offering on November 6, 2026, terminating its prior program with approximately $170,134,000 remaining unsold.
AHR · American Healthcare REIT, Inc.
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
Up next
Latest documents
American Healthcare REIT, Inc. reported nine-month 2026 revenue of $2,067,173 thousand, up from $1,656,043 thousand in 2025, driven by acquisitions and higher resident occupancy. As of September 30, 2026, its portfolio comprised 366 buildings totaling approximately 25,437,000 square feet.
American Healthcare REIT raised full-year 2026 NFFO per diluted share guidance to $223 to $226 from $215 to $219 after third-quarter same-store NOI grew 13.8 percent; net debt to annualized adjusted EBITDA improved to 1.9 times.
American Healthcare REIT, Inc. reported third-quarter NFFO of $0.58 per diluted share and 13.8% Same-Store NOI growth, raising 2026 NFFO guidance to $2.23 to $2.26 and Same-Store NOI growth guidance to 12.0% to 14.0%.
Metrics snapshot
Useful current figures from the complete screener profile.
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Still-open targets the latest release did not restate under the same label.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| NAREIT FFO attributable to controlling interest non-GAAP | 97.98M | Three Months Ended June 30, 2026 filing | — |
| Net operating income non-GAAP | 137.24M | Three Months Ended June 30, 2026 filing | — |
| Normalized FFO attributable to controlling interest non-GAAP | 105.19M | Three Months Ended June 30, 2026 filing | — |
GAAP → non-GAAP reconciliationNAREIT FFO attributable to controlling interest 97.98M (non-GAAP)
+2.79M Transaction, transition and restructuring costs
+300K Amortization of above- and below-market leases
+12K Amortization of closing costs — debt security investment
-354K Change in deferred rent
+5.77M Non-cash impact of changes to equity instruments
-223K Non-cash income tax benefit
-711K Capitalized interest
+147K Loss on debt extinguishments
-357K (Gain) loss in fair value of derivative financial instruments
-75K Foreign currency (gain) loss
+0K Adjustments for unconsolidated entities
-79K Adjustments for noncontrolling interests
= Normalized FFO attributable to controlling interest 105.19M
|
|||
| Segment net operating income non-GAAP | $137.24M | Three Months Ended June 30, 2026 filing | — |
| Annualized Cash NOI non-GAAP | 571.84M | as of June 30, 2026 | — |
| NAREIT FFO per common share attributable to controlling interest — diluted | $0.99 | Six Months Ended June 30, 2026 | — |
| Normalized FFO per common share attributable to controlling interest — diluted non-GAAP | $1.05 | Six Months Ended June 30, 2026 | — |
| Revenue per square foot | $32.29 | Q2 2026 | — |
| RevPOR | $5,754 | Q2 2026 | — |
| Same-Store NOI non-GAAP | 219.32M | Six Months Ended June 30, 2026 | — |
| Same-Store properties non-GAAP | 115 | Q2 2026 | — |
| Total average Occupancy | 89.5% | Q2 2026 | — |
| Trailing 12-months Retention | 65.2% | as of June 30, 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
REIT - Healthcare Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
AHR
this stock
American Healthcare REIT, Inc.
|
$13.41B | +22.8% | +9.1% | 115.6 | 14.5% |
|
WELL
Welltower Inc.
|
$179.34B | +31.7% | +35.6% | 106.3 | 2.4% |
|
VTR
Ventas, Inc.
|
$47.02B | +14.9% | +18.5% | 167.8 | 2.8% |
|
OHI
Omega Healthcare Investors Inc
|
$14.32B | +6.1% | +13.2% | 18.9 | 4.8% |
|
DOC
Healthpeak Properties, Inc.
|
$13.78B | +24.3% | +4.5% | 37.0 | 3.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every section- Filed
- Nov 6, 2026
- This year
- 31
American Healthcare REIT, Inc. reported nine-month 2026 revenue of $2,067,173 thousand, up from $1,656,043 thousand in 2025, driven by acquisitions and higher resident occupancy. As of September 30, 2026, its portfolio comprised 366 buildings totaling approximately 25,437,000 square feet.
ViewPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| AHR | -0.2% | +8.6% | +13.3% | +8.0% | +22.8% |
| SPY | +2.6% | -1.2% | +0.5% | -0.2% | +10.6% |
| vs SPY | -2.8% | +9.7% | +12.8% | +8.1% | +12.2% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.